Market Tracker

02/05 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

92.50
Delayed Data
As of Feb 05
 -6.44 / -6.51%
Today’s Change
49.65
Today|||52-Week Range
114.00
-14.68%
Year-to-Date

Today’s Trading

Previous close98.94
Today’s open98.70
Day’s range92.06 - 100.50
Volume545,351
Average volume (3 months)372,098
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+121.55%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+31.78%
P/E ratio7.6
Price/Sales17.67
Price/Book68.80

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-4.53-9.43%
RAREUltragenyx Pharmaceu...-0.41-0.76%
ACORAcorda Therapeutics ...-0.61-1.64%
MDCOMedicines Co-1.86-5.66%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 10, 2016
EPS forecast (this quarter)$0.65
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts